Devices › Device types
FDA product code KRA · class 2 · Cardiovascular
Catheter, continuous flush: medical device reports filed with FDA
9,056 reports carry this product code, 1992–2026; 23 brands with a page.
- 9,056
- reports with this product code
- 0% of all MAUDE reports
- 813
- reports, 12 months to August 2026
- 1,193 in the 12 months before
- 74.2%
- classified as malfunction
- 62.3% across all reports
- 4%
- classified as death, as reported
- 0.9% across all reports
Product code KRA is FDA's classification for "Catheter, continuous flush" (cardiovascular panel), a class 2 device. 9,056 medical device reports carry this product code, 0% of the MAUDE database, from July 1992 to August 2026.
813 reports arrived in the 12 months to August 2026, down 32% from 1,193 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (74.2%), injury (20.9%) and death (4%). 23 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Echelon | 711 | 584 | 3.2% | 72.8% |
| Marathon | 486 | 66 | 5.9% | 54.9% |
| Rebar | 456 | 108 | 9% | 62.8% |
| Prowler Select Microcatheters | 452 | 0 | 1.5% | 88.1% |
| Cxi Support Catheter | 406 | 23 | 0% | 79.7% |
| Marksman | 405 | 77 | 6.7% | 63% |
| Prowler Select Plus 150/5cm | 398 | 1 | 0.2% | 96.5% |
| Cathera | 321 | 0 | 7.3% | 66.1% |
| Renegade? HI-FLO? Kit | 266 | 15 | 0% | 96.6% |
| Prowler Select | 185 | 461 | 0.1% | 98.5% |
| Direxion? | 151 | 23 | 0% | 89.4% |
| Marathon Micro Catheter | 150 | 0 | 2.3% | 35.5% |
| Renegade? HI-FLO? FATHOM? System | 150 | 11 | 0% | 96% |
| AngioJet SOLENT Proxi | 142 | 5 | 4.6% | 84.6% |
| AngioJet SOLENT omni | 61 | 26 | 1.3% | 93.1% |
| Angiojet Zelantedvt | 56 | 0 | 5.3% | 76.3% |
| Phenom Catheter | 41 | 406 | 3.1% | 80.6% |
| Renegade | 35 | 0 | 0.3% | 95.7% |
| Swan-Ganz Ccombo V | 4 | 88 | 0.6% | 97% |
| Onyx | 1 | 69 | 13.4% | 12% |
| Onyx Avm | 1 | 27 | 4.9% | 21.7% |
| Performer Introducer | 1 | 15 | 1.3% | 79.5% |
| Rist | 1 | 53 | 3% | 47% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Micro Therapeutics Ev3 | 1,855 | 20.5% |
| Medos International Sarl | 667 | 7.4% |
| Cordis Neurovascular | 548 | 6.1% |
| Boston Scientific - Cork | 480 | 5.3% |
| Covidien Irvine | 356 | 3.9% |
| Ev3 Neurovascular | 305 | 3.4% |
| Codman And Shurtleff | 270 | 3% |
| Covidien | 268 | 3% |
| Medtronic Dominicana | 260 | 2.9% |
| Medtronic Mexico S De R L De Cv | 154 | 1.7% |
| Cook | 113 | 1.2% |
| Merit Medical Systems | 93 | 1% |
| Edwards Lifesciences Pr | 92 | 1% |
| Boston Scientific - Maple Grove | 65 | 0.7% |
| Icu Medical De Mexico S De R L De C V | 49 | 0.5% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Physical resistance/sticking | 1,519 | 16.8% |
| Breakthe device broke | 1,506 | 16.6% |
| Leak/splashthe device leaked | 477 | 5.3% |
| Material deformation | 358 | 4% |
| Material separation | 357 | 3.9% |
| Fracturea broken bone | 332 | 3.7% |
| Difficult to removethe device was hard to remove | 316 | 3.5% |
| Detachment of device or device componentpart of the device came off | 290 | 3.2% |
| Physical resistance | 283 | 3.1% |
| Obstruction of flow | 269 | 3% |
| Burst container or vessel | 263 | 2.9% |
| Material rupture | 249 | 2.7% |
| Entrapment of device | 211 | 2.3% |
| Detachment of device component | 192 | 2.1% |
| Difficult to advance | 173 | 1.9% |
| Device dislodged or dislocated | 168 | 1.9% |
| Device damaged by another device | 158 | 1.7% |
| Fluid/blood leak | 157 | 1.7% |
| Material integrity problema problem with the device material | 146 | 1.6% |
| Retraction problem | 109 | 1.2% |
Questions about catheter, continuous flush reports
What is product code KRA?
FDA's classification code for "Catheter, continuous flush", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
9,056 reports through August 2026, 813 of them in the latest 12 months.
Which brands appear most often?
Echelon (711), Marathon (486), Rebar (456), Prowler Select Microcatheters (452) and Cxi Support Catheter (406). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.